BioSpace News Archive

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, reported financial results for the quarter ended March 31, 2022 and provided key pipeline and business updates.

Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its financial results for the first quarter of 2022.

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced financial results for the first quarter of 2022 and provided an update on the Company’s business operations and clinical development programs.

IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022 at 9:30 a.m. EST in New York.

Anavex Life Sciences Corp. reported financial results for its fiscal quarter ended March 31, 2022.

Taysha Gene Therapies, Inc. announced oral and poster presentations and a company-sponsored symposium at the upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy taking place in Washington, D.C. from May 16-19, 2022.

Panag Pharma Inc (Panag), a subsidiary of Tetra Bio-Pharma, will collect royalties on sales on products produced with the technology True North has licensed from Panag.

Haemonetics Corporation announced that it will host an Investor Day in Boston on Wednesday, June 29, 2022 beginning at 10:00 AM EDT.

Aurinia Pharmaceuticals Inc. issued its financial results for the first quarter ended March 31, 2022.

Immuneering Corporation, a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, reported financial results for the first quarter ended March 31, 2022 and provided recent business highlights.